See more : TriState Capital Holdings, Inc. (TSCBP) Income Statement Analysis – Financial Results
Complete financial analysis of Greenfern Industries Limited (GFI.NZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Greenfern Industries Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Technology One Limited (TNE.AX) Income Statement Analysis – Financial Results
- Public Joint Stock Company Magnit (MGNT.IL) Income Statement Analysis – Financial Results
- Theralase Technologies Inc. (TLT.V) Income Statement Analysis – Financial Results
- Dialogue Health Technologies Inc. (DLHTF) Income Statement Analysis – Financial Results
- Megatech Corporation (MGTC) Income Statement Analysis – Financial Results
Greenfern Industries Limited (GFI.NZ)
About Greenfern Industries Limited
Greenfern Industries Limited operates as an entrepreneurial led licensed medicinal cannabis research and biotechnology company in New Zealand. It operates in the medicinal cannabis, industrial hemp, hemp food, and body care spaces. The company was incorporated in 2018 and is headquartered in Auckland, New Zealand.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 377.57K | 999.47K | 336.73K |
| Cost of Revenue | 97.59K | 512.11K | 207.21K |
| Gross Profit | 279.98K | 487.37K | 129.52K |
| Gross Profit Ratio | 74.15% | 48.76% | 38.46% |
| Research & Development | 0.00 | 352.21K | 179.72K |
| General & Administrative | 1.42M | 2.06M | 2.04M |
| Selling & Marketing | 294.81K | 199.17K | 41.89K |
| SG&A | 1.72M | 2.26M | 2.08M |
| Other Expenses | -14.76K | -193.70K | 148.82K |
| Operating Expenses | 1.72M | 2.26M | 2.08M |
| Cost & Expenses | 1.82M | 2.77M | 2.29M |
| Interest Income | 0.00 | 0.00 | 0.00 |
| Interest Expense | 120.37K | 75.88K | 159.00 |
| Depreciation & Amortization | 0.00 | 119.83K | 114.68K |
| EBITDA | -1.45M | -1.83M | -2.05M |
| EBITDA Ratio | -384.65% | -196.26% | -578.88% |
| Operating Income | -1.45M | -1.96M | -2.06M |
| Operating Income Ratio | -384.65% | -196.26% | -612.93% |
| Total Other Income/Expenses | -120.37K | -285.44K | 148.65K |
| Income Before Tax | -1.57M | -2.04M | -1.95M |
| Income Before Tax Ratio | -416.53% | -203.85% | -578.93% |
| Income Tax Expense | 0.00 | -237.65K | 34.30K |
| Net Income | -1.57M | -2.04M | -1.95M |
| Net Income Ratio | -416.53% | -203.85% | -578.93% |
| EPS | -0.03 | -0.04 | -0.04 |
| EPS Diluted | -0.03 | -0.04 | -0.04 |
| Weighted Avg Shares Out | 53.59M | 53.59M | 53.59M |
| Weighted Avg Shares Out (Dil) | 53.59M | 53.59M | 53.59M |
Source: https://incomestatements.info
Category: Stock Reports